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Background: Protein interactions play an important role in the pyrroloquinoline quinone biosynthetic pathway.
Results: PqqD binds PqqA, the peptide substrate, with a submicromolar KD, and they form a ternary complex with PqqE.
Conclusion: PqqD is a peptide chaperone that interacts with PqqE.
Significance: Orthologous PqqDs may play similar roles in other peptide modification pathways.
Pyrroloquinoline quinone (PQQ) is a product of a ribosomally
synthesized and post-translationally modified pathway consist-
ing of five conserved genes, pqqA-E. PqqE is a radical S-adeno-
sylmethionine (RS) protein with a C-terminal SPASM domain,
and is proposed to catalyze the formation of a carbon-carbon
bond between the glutamate and tyrosine side chains of the pep-
tide substrate PqqA. PqqD is a 10-kDa protein with an unknown
function, but is essential for PQQ production. Recently, in Kleb-
siella pneumoniae (Kp), PqqD and PqqE were shown to interact;
however, the stoichiometry and KD were not obtained. Here, we
show that the PqqE and PqqD interaction transcends species,
also occurring in Methylobacterium extorquens AM1 (Me). The
stoichiometry of the MePqqD and MePqqE interaction is 1:1
and the KD, determined by surface plasmon resonance spectros-
copy (SPR), was found to be 12 M. Moreover, using SPR and
isothermal calorimetry techniques, we establish for the first
time that MePqqD binds MePqqA tightly (KD 200 nM). The
formation of a ternary MePqqA-D-E complex was captured by
native mass spectrometry and the KD for the MePqqAD-
MePqqE interaction was found to be 5 M. Finally, using a
bioinformatic analysis, we found that PqqD orthologues are
associated with the RS-SPASM family of proteins (subtilosin,
pyrroloquinoline quinone, anaerobic sulfatase maturating
enzyme, and mycofactocin), all of which modify either peptides
or proteins. In conclusion, we propose that PqqD is a novel pep-
tide chaperone and that PqqD orthologues may play a similar
role in peptide modification pathways that use an RS-SPASM
protein.
Ribosomally synthesized and post-translationally modified
peptides constitute a major class of natural products consisting
of bioactive compounds such as antibiotics (1–3), quorum
sensing molecules (4, 5), metal chelators (6), and redox cofac-
tors (7). Certain ribosomally derived products rely on radical
S-adenosylmethionine enzymes (herein referred to as RS pro-
teins) to catalyze the formation of -carbon thioether bonds or
carbon-carbon bonds (8, 9). In the subtilosin and the pyrrolo-
quinoline quinone (PQQ)2 pathways, the RS protein also con-
tains a C-terminal extension referred to as a SPASM domain
(subtilosin, PQQ, anaerobic sulfatase maturating enzyme, and
mycofactocin). RS-SPASM proteins are typically found in pep-
tide or protein modification pathways (10, 11). In some cases,
the RS-SPASM protein is fused to a 90 amino acid protein
(e.g. AlbA) or, alternatively, the RS-SPASM gene is located adja-
cent to a gene encoding for a 90 amino acid protein (e.g.
PqqE). The function of the small protein and its relationship to
RS-SPASM proteins remains unknown and, its role in the PQQ
biosynthetic pathway is the focus of this paper.
PQQ (4,5-dihydro-4,5-dioxo-1H-pyrrolo[2,3-f] quinolone-
2,7,9-tricarboxylic acid) is a redox active tricyclic o-quinone
that serves as a cofactor, predominantly, for prokaryotic alcohol
and sugar dehydrogenases (12, 13). Biosynthesis of PQQ relies
on five strictly conserved gene products, pqqABCDE (8, 9,
14 –16). In all cases, pqqA encodes for a short peptide, typically
20 –30 amino acids in length, containing a conserved glutamate
and tyrosine that serve as the backbone in PQQ biogenesis (Fig.
1). The glutamate and tyrosine undergo post-translational
modifications to form the intermediate 3a-(2-amino-2-car-
boxyethyl)-4,5-dioxo-4,5,6,7,8,9-hexahydroquinoline-7,9-di-
carboxylic acid (AHQQ). Of the pqq gene products, PqqC is the
most characterized and has been shown to catalyze the eight-
electron oxidation and ring cyclization of AHQQ to form PQQ
(17, 18). The functions of the remaining pqq gene products
remain elusive, although, a recent bioinformatic analysis pro-
posed that PqqB, a metallo--lactamase-fold member, oxidizes
some form of intermediate that leads to the formation of
AHQQ (15). PqqE is an RS-SPASM protein and has been shown
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to cleave S-adenosylmethionine to methionine and 5-deoxy-
adenosine in an uncoupled reaction (19). PqqE is proposed to
catalyze the C-C bond formation between the glutamate and
tyrosine; however, efforts to couple S-adenosylmethionine
cleavage to the cross-linking have thus far been unsuccessful
(19).
PqqD is a small protein (90 amino acids) with no detectable
cofactor and few strictly conserved residues. PqqD can be found
as an individual protein, as a C-terminal gene fusion to PqqC
(e.g. Methylobacterium extorquens AM1 PqqCD) or as a N-ter-
minal gene fusion to PqqE (e.g. Methylocystis sp. SC2 PqqDE). A
crystal structure has been solved for Xanthomonas campestris
PqqD (XcPqqD, PDB number 3G2B). Analysis of the structure
indicates that XcPqqD forms a saddle-like dimer under crystal-
lization conditions (Fig. 2) but little functional information
could be derived (20). A bioinformatic analysis on PqqD could
not identify functionally relevant residues (15), adding to the
ambiguity of the role that PqqD plays in PQQ biogenesis. How-
ever, recent electron paramagnetic resonance (EPR) and hydro-
gen-deuterium exchange mass spectrometry experiments have
shown that Klebsiella pneumonia PqqE (KpPqqE) and PqqD
(KpPqqD) interact, suggesting that the formation of a macro-
molecular complex may lead to function of one or more
enzymes (21).
Although the formation of a KpPqqD-KpPqqE complex has
been reported (19), a detailed biophysical characterization of
the interaction has not yet been completed. To learn more
about the interaction, we determined the stoichiometry of the
KpPqqD-KpPqqE complex using native mass spectrometry
experiments. We expanded our investigations into M.
extorquens AM1 (Me) and determined the stoichiometry and
dissociation constant (KD) for the MePqqD-MePqqE interac-
tion. We also determined, through various biophysical tech-
niques, that MePqqD binds the peptide MePqqA with a submi-
cromolar KD independent of the presence of MePqqE.
Additionally, we were able to capture the MePqqADE ternary
complex by mass spectrometry and establish the KD for the
MePqqAD-MePqqE interaction. Last, we use small angle x-ray
scattering to demonstrate that the KpPqqD adopts a different
oligomerization and conformational state than was found for
the XcPqqD crystal.
EXPERIMENTAL PROCEDURES
Materials—All restriction enzymes and T4 DNA ligase were
purchased from New England BioLabs (Ipswich, MA). Poly-
merase was purchased from Agilent (Santa Clara, CA). Oligonu-
cleotides were purchased from Eurofins (Huntsville, AL). DNA
sequencing was conducted by the University of California DNA
Sequencing Facility (Berkeley, CA). The peptide MePqqA (Uni-
prot number Q49148) was synthesized and purified to 80%
purity by CPC Scientific (Emeryville, CA) and used without
further purification. The peptide sequence, KWAAPIVSEIS-
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FIGURE 1. Abbreviated PQQ biosynthesis. Formation of PQQ from conserved PqqA glutamate and tyrosine residues.
FIGURE 2. Structure of XcPqqD. The XcPqqD (PDB code 3G2B) dimer is
depicted in ribbon form with each monomer differentiated by color. Each
elongated monomer consists of a three -helix bundle and a -turn-
domain connected by a -strand. Phosphate ligands from crystallization
buffer are shown in orange. The box indicates the portion of the crystal struc-
ture used to model a compact XcPqqD monomer.
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VGMEVTYSESAEIDTFN, incorporated Ser-11 in place of the
wild-type Cys to eliminate dimer formation.
Preparation of Recombinant PqqB—Wild-type PqqB-His6
(UniProt number Q49149) was prepared by using a PCR-based
strategy. Accordingly, the gene was amplified by PCR using
genomic DNA from M. extorquens AM1 (ATCC, Manassas,
VA) as template, commercial oligonucleotides as primers, and
Pfu Turbo as the polymerase. The PCR product was digested by
the restriction enzymes NdeI and XhoI and then purified by
agarose gel electrophoresis. The gene was ligated to an NdeI-
and XhoI-digested pET24b vector (EMD Millipore) using T4
DNA ligase. The cloned gene was verified by DNA sequencing
and then used to transform competent Escherichia coli
BL21(DE3) cells for gene expression. The PqqB/pET24b-trans-
formed E. coli BL21(DE3) cells were grown aerobically at 37 °C
in LB media containing 50 g/ml of kanamycin. Production of
PqqB-His6 was induced by the addition of 1 mM isopropyl -D-
galactopyranoside and 30 mg/liter of ZnCl2 once the cell den-
sity had reached A600 0.6. Following a 12-h induction period
at 19 °C, the cells were harvested by centrifugation at 6,500 rpm
for 10 min. The cells were suspended in five times the mass of
cell paste of 50 mM Tris buffer (pH 7.9), 50 mM imidazole, and
200 mM NaCl (lysis buffer). The cells were lysed by sonication
and the lysate was centrifuged at 20,000 rpm for 15 min. The
supernatant was loaded onto a 5-ml HisTrap FF column (GE
Healthcare) and the column was washed at 4 °C with lysis buffer
to remove non-tagged protein and then with 50 mM Tris (pH
7.9), 300 mM imidazole, and 200 mM NaCl (elution buffer) to
elute the tagged protein. The desired fractions were combined,
concentrated, and buffer exchanged over PD-10 columns (GE
Healthcare) equilibrated with 50 mM Tris (pH 7.9), 150 mM
NaCl. Fractions containing PqqB-His6 were pooled and con-
centrated prior to being flash frozen. Column fractions were
monitored by solution absorbance at 280 nm and by carrying
out SDS-PAGE analysis. Yield was 60 mg/liter of culture.
Preparation of Recombinant PqqCD—Wild-type MePqqCD
(UniProt number Q49150) was cloned using procedures similar
to PqqB. The amplified PCR products were digested with NdeI
and XhoI and purified by agarose electrophoresis. The
restricted digested PCR product was ligated to an NdeI- and
XhoI-digested pET28a vector (EMD Millipore) using T4 DNA
ligase. The cloned gene was sequence verified and used to trans-
form E. coli BL21(DE3) for gene expression. The His-tagged
encoded MePqqCD/pET28a-transformed E. coli BL21(DE3)
cells were grown aerobically at 37 °C in LB media containing 50
g/ml of kanamycin. Production and purification of His6-
MePqqCD followed the same procedures listed for MePqqB-
His6 except that ZnCl2 was not added upon induction and 1 mM
TCEP was added to all buffers as a precaution. The desired
fractions were combined, concentrated, and buffer exchanged
over PD-10 columns equilibrated with 50 mM Tris (pH 7.9), 150
mM NaCl, and 1 mM TCEP prior to being flash frozen. The
homogeneity was confirmed by SDS-PAGE analysis. Yield for
His6-MePqqCD was 24 mg/liter of culture.
Preparation of Recombinant PqqD—For experiments using
only native MePqqD protein (amino acids 280 –372), a
MePqqD/pET24b was constructed using the NdeI and XhoI
restriction sites and expressed as described for His6-MePqqCD.
For native MePqqD, cells were suspended in five times the mass
of cell paste of 50 mM HEPES buffer (pH 6.8). The cells were
lysed by sonication and clarified by centrifugation at 20,000
rpm for 15 min. The clarified lysate was loaded onto a pre-
equilibrated 20-ml DEAE-Sepharose FF column (GE Health-
care), washed with lysis buffer, and eluted with a 0 – 0.5 M NaCl
gradient in 50 mM HEPES buffer (pH 6.8) over 25 column vol-
umes. MePqqD eluted between 100 and 200 mM NaCl. The
MePqqD containing fractions were pooled, equilibrated with
17% saturated NH4SO4, and loaded onto a pre-equilibrated
HiPrep 16/10 Phenyl FF column (GE Healthcare). The column
was washed with 50 mM HEPES (pH 6.8) and 17% saturated
NH4SO4 and MePqqD was eluted with a 17– 0% NH4SO4 gra-
dient over 15 column volumes. MePqqD eluted between 9 and
12% saturated NH4SO4. MePqqD containing fractions were
pooled, concentrated in a 10-kDa MWCO spin column (Milli-
pore), and further purified over a 26/60 Sephacyl S-200 size
exclusion column equilibrated with 50 mM HEPES (pH 6.8) and
150 mM NaCl. Fractions containing MePqqD were pooled and
concentrated prior to being flash frozen. Column fractions
were monitored by solution absorbance at 280 nm and by SDS-
PAGE analysis. Yield was 6 mg/liter. The His6-MePqqD protein
was prepared from a MePqqD/pET28a construct following the
described procedures for the His6-MePqqCD protein. Yield for
His6-MePqqD was 8 mg/liter of culture.
Preparation of Recombinant PqqE—MePqqE (UniProt num-
ber P71517) was cloned into pET28a using the NdeI and XhoI
restriction sites from genomic DNA. The cloned gene was
sequence verified and used to transform E. coli BL21(DE3)
harboring the suf operon plasmid pPH149, for gene expres-
sion. The MePqqE/pET28a and pPH149-transformed E. coli
BL21(DE3) cells were grown aerobically at 37 °C in TB media
containing 50 g/ml of kanamycin and 35 g/ml of chloram-
phenicol. Once the cell density reached A600 0.6, 5 mM fuma-
rate and 50 M Fe(III) citrate were added and the flasks were
stoppered to transition from aerobic to anaerobic conditions.
After 30 min of anaerobic growth at 37 °C, production of His6-
MePqqE was induced with 0.4 mM isopropyl -D-galactopyra-
noside. Following a 12-h induction period at 19 °C, the cells
were harvested by centrifugation at 6,500 rpm for 10 min and
frozen. The cells were transferred to an anaerobic chamber sus-
pended in five times the mass of cell paste of degassed 50 mM
Tris buffer (pH 7.9), 50 mM imidazole, 1 mM TCEP, and 200 mM
NaCl (lysis buffer). BugBuster (Novagen) supplemented with
Benzonase (Novagen) was used to lyse the cells following the
manufacturer’s guidelines. The lysate was transferred to sealed
tubes and centrifuged at 20,000 rpm for 15 min. The sealed
tubes containing clarified lysate were transferred to the anaer-
obic chamber and the supernatant was loaded onto a 5-ml His-
Trap FF column (GE Healthcare) by a peristaltic pump. The
column was washed at 22 °C with lysis buffer to remove non-
tagged protein and then with degassed 50 mM Tris (pH 7.9), 300
mM imidazole, 1 mM TCEP, and 200 mM NaCl (elution buffer)
to elute the tagged protein. The desired fractions were com-
bined, concentrated, and buffer exchanged over PD-10 col-
umns equilibrated with degassed 50 mM Tris (pH 7.9), 100 mM
NaCl, 5% glycerol, and 1 mM TCEP prior to being flash frozen in
sealed vials. The homogeneity was confirmed by SDS-PAGE
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analysis. Yield for His6-MePqqE was 18 mg/liter of culture. For
native MePqqE, thrombin was used to cleave the N-terminal
His6 tag, which was removed by passage through a 1-ml nickel-
nitrilotriacetic acid column. The C-terminally His-tagged
MePqqE-His6 was purified as described above from E. coli
BL21(DE3) harboring the plasmid pPH149 and the plasmid
MePqqE/pET24b where MePqqE was cloned into the NdeI and
XhoI restriction sites of pET24b. Yield for MePqqE-His6 was 18
mg/liters of culture.
Construction of the MePqqDE Fusion—A MePqqDE fusion
was constructed through a PCR-based strategy using commer-
cial oligonucleotides as primers and MePqqE/pET28a and
MePqqD/pET24b as templates. The MePqqD gene was ampli-
fied with a 5-3 oligonucleotide encoding a NdeI restriction
site and a 3-5 oligonucleotide encoding for a (GGGGS)2
repeat and a BamHI restriction site. The MePqqE gene was
amplified with a 5-3 oligonucleotide encoding for a (GGGGS)
linker and a BamHI restriction site and the original 3-5 oligo-
nucleotide encoding a XhoI restriction site. The PCR products
were digested with the respective enzymes and a triple ligation
strategy was used to ligate the products to each other and to
pET28a digested with NdeI and XhoI. The purification of His6-
MePqqDE was identical to the procedures listed for His6-
MePqqE. Yield for His6-MePqqDE was 23 mg/liter of culture.
Analytical Size Exclusion Chromatography (SEC)—Analyti-
cal SEC was performed on a Superdex 75 10/300 GL (GE
Healthcare) outfitted to an AKTA FPLC (GE Healthcare) with a
flow rate of 0.5 ml/min at 4 °C. The mobile phase was 50 mM
HEPES (pH 7.5) and 150 mM NaCl buffer and 100 g of protein
was injected for each run. The elution volume was monitored
by a change in absorbance at 280 nm. A calibration curve was
constructed from aprotonin (6.5 kDa, eluted at 15.1 ml), ribo-
nuclease A (13.7 kDa, eluted at 13.5 ml), myoglobin equine
from skeletal muscle (17 kDa, eluted at 12.3 ml), carbonic anhy-
drase (29 kDa, eluted at 12.3 ml), and albumin (66 kDa, eluted at
13.5 ml) (Sigma). The dead volume was determined by blue
dextran (Sigma).
Isothermal Titration Calorimetry Analysis—Recombinant
MePqqD, His6-MePqqCD, and His6-MePqqDE were buffer
exchanged into PBS buffer (Corning) over a PD-10 (GE Health-
care) column. MePqqA was dissolved into PBS to make a 0.5
mM stock solution. Calorimetric analysis was performed in trip-
licate on a MicroCal AutoCal ITC200 (GE Healthcare). The
reference cell was filled with water. In a typical experiment, the
sample cell was loaded with a 20 M solution of protein. The cell
solution was titrated with an initial 1.2-l injection followed by
12 aliquots of 3.4 l of a 200 M MePqqA solution. The
obtained heat signals from the ITC were integrated using the
Origin software package supplied by GE Healthcare to obtain
the binding isotherms. The data, except from the first injection,
were fitted to a single site-binding model by regression routines
programmed into Origin defined by Equation 1. The expression
to calculate the binding constant K from the number of binding
sites occupied by the ligand (n, set to 1), change in enthalpy
(H), bulk concentration (Xt) of ligand, and bulk concentration
(Mt) of macromolecule in a volume Vo is shown in Equation 1.
Q 
nMtHVo
2 1  XtnMt  1nKMt  1  XtnMt
2

4Xt
nMt

(Eq. 1)
Nanoelectrospray Ionization Mass Spectrometry (NanoESI-
MS) of Native Proteins—Recombinant His6-KpPqqE, KpPqqD,
MePqqE-His6, and MePqqD were buffer exchanged into 25 mM
ammonium bicarbonate (pH 7.9) using pre-equilibrated PD-10
columns (GE Healthcare). Solid MePqqA was dissolved directly
into the ammonium bicarbonate buffer. Mass spectra of native
proteins and complexes were acquired using a quadrupole
time-of-flight (Q-TOF) mass spectrometer equipped with a
nano-Z-spray nanoESI source (Q-TOF Premier, Waters, Bev-
erly, MA). Acquisition of spectra was performed following pre-
viously described procedures (22). Mass spectra of the intact
proteins and complexes were processed using MassLynx soft-
ware (version 4.1, Waters). The KpPqqE and KpPqqD experi-
ments contained 10 M His6-KpPqqE with or without 40 M
KpPqqD. The MePqqE and MePqqD experiments contained 10
M MePqqE-His6 with and without 50 M MePqqD. To exam-
ine the ternary complex, experiments contained 10 M
MePqqE-His6, 50 M MePqqD, and 50 M MePqqA.
Surface Plasmon Resonance (SPR) Measurements—Binding
studies were conducted in triplicate on a Biacore T100 (Biacore,
GE Healthcare). His6-tagged proteins were immobilized to a
Series NTA chip (Biacore, GE Healthcare) and peptide or puri-
fied native PqqE was injected as analyte. Flow cell 1 was not
immobilized with protein and served as the reference channel.
Ligands and analyte were diluted into HBS-P buffer (GE
Healthcare). The His6-tagged proteins were injected at 10 nM
and the immobilization level ranged between 100 and 500
response units depending on the analyte. Seven to 9-fold serial
dilutions of analyte were injected for 30 s at a flow rate of 30
l/min followed by a 60-s dissociation phase. After each cycle
the surface was regenerated by injecting 300 mM EDTA fol-
lowed by 500 M NiCl2 and a 3 mM EDTA wash. Binding affin-
ities were determined from steady state analysis of the maxi-
mum steady state response. Final data analysis, plotting and
curve fitting were performed by Prism 5 software (Prism).
Small Angle X-ray Scattering (SAXS) Analysis—KpPqqD,
used for all SAXS experiments, was frozen and hand delivered
to the work site. KpPqqD was prepared as previously
described (21) and buffer exchanged into 50 mM Tris (pH
7.9), 100 mM NaCl, 1 mM TCEP, and 2.5% glycerol by SEC.
Samples were diluted to 1, 2, 3, 4, and 5 mg/ml at 4 °C. Syn-
chrotron radiation x-ray scattering data were collected using
standard procedures on the 4-2 Beamline at the Stanford Syn-
chrotron Radiation Lightsource (SSRL). SAXS data were col-
lected on a MarCCD225 detector at wavelength of 1.3 Å. Fifteen
individual 1-s samples were collected at each concentration and
buffer scans were collected before each experiment.
Data were integrated, averaged, and buffer subtracted using
SasTool (23). PRIMUS was used to calculate a Guinier approx-
imation, where a plot of ln[I(q)] and q2 is linear, as well as to
calculate a radius of gyration (Rg) and distribution of distances
(23). GNOM was used to generate the pair distribution function
P(r) and the maximum particle distribution (Dmax) (23, 24).
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DAMMIF and PDB2VOL were used to generate the ab initio
shape reconstruction employing the parameters defined by
GNOM (25, 26). The predicted SAXS profile for the XcPqqD
dimer and monomer (PDB code 3G2B) was generated and fit-
ted to experimental data by FOXS (27). Chimera was used to fit
the atomic structure of XcPqqD into the KpPqqD envelope
generated by SITUS (26, 28). SAXSMOW was used to deter-
mine the relative molecular weight from the SAXS measure-
ment (29).
Construction of the SPASM Domain Sequence Similarity
Network—The Interpro SPASM domain designation (IPR023885)
was used to generate a sequence similarity network using the
EFI-EST tool (30 –33). The network was parsed by an E value of
1045 and the subsequent sequences, with 60% identity, were
combined into nodes. The sequence similarity network was
visualized and annotated using Cytoscape (32). The gene con-
text of representative node sequences was further analyzed on
the EnsemblBacteria website or the NCBI gene website. The
gene context of representative sequences for each node was
searched within a five gene sliding window on the same DNA
strand for a 90 –120-amino acid PqqD-like gene (annotated as
PqqD or as unknown) and a peptide up to 70 amino acids. The
length of the peptide was chosen based on the extreme cases of
PqqA peptides with sequence lengths annotated as 70 amino
acids (e.g. Uniprot numbers I0G208, G7DC35, and A9W3R3).
RESULTS
Analysis of the PqqD Oligomeric Structure from K.
pneumoniae—SEC was employed to estimate the molecular
weight, and thereby the oligomerization state, for KpPqqD.
MePqqD was not analyzed due to the lack of tryptophan in the
protein, making detection by absorbance difficult. The SEC elu-
tion profile for KpPqqD showed a single peak (Fig. 3A) with an
estimated molecular mass of 14.9 kDa (KpPqqD monomer,
10,435 Da) calculated from the standard curve (Fig. 3B). The
calculated Mr and the presence of a single elution peak sug-
gested that KpPqqD could be a monomer in solution. Upon
finding that the solution oligomerization state for KpPqqD may
be different from the dimer found in a crystal structure of the
homologous XcPqqD (30 and 44% sequence identity to
KpPqqD and MePqqD respectively), we turned to small angle
x-ray scattering (SAXS) to explore further the solution
structure.
Various concentrations of KpPqqD (1, 2, 3, 4, and 5 mg/ml)
were analyzed by SAXS (Fig. 3C). Inspection of the low q
Guinier region is useful to evaluate the presence of sample
aggregation or concentration-dependent scattering (34). The
Guinier analysis of the low q region of individual SAXS profiles
extrapolated to the zero scattering angle qualitatively demon-
strates that KpPqqD is not aggregated. The radius of gyration
(Rg), determined from the Guinier analysis, is the root mean
square distance from the center of mass to each electron. The Rg
can be used as an indicator of protein compactness because it
has an approximate relationship with the length of the protein
(35, 36). The Rg values were determined for each SAXS profile
and plotted against concentration (Fig. 3D). The Rg values were
fitted to a linear equation. The near zero slope (m  0.15) indi-
cates that the protein conformation and oligomerization state
are homogeneous and concentration independent for the
range analyzed.
The SAXS profiles for each concentration were averaged to
generate a combined SAXS profile (Fig. 3E). The averaged
SAXS profile was used for the remaining data analysis. The Rg
determined from the averaged SAXS profile was found to be
15.43  0.04 Å. This experimental Rg does not agree with the
theoretical Rg for the monomer or dimer (20.48 and 21.76 Å,
respectively) calculated from the XcPqqD crystal structure
using CRYSOL (37). Moreover, the present data provided a
calculated maximum length for the protein (Dmax), and this was
found to be 55.6 Å, dissimilar from the theoretical Dmax for the
XcPqqD monomer or dimer (66.7 and 74.3 Å, respectively). The
SAXS profile for KpPqqD overlaid with the monomeric or
dimeric calculated SAXS profile derived from the crystal struc-
ture by CRYSOL shows (Fig. 3E, blue and cyan, respectively)
how the solution structure and the crystal structure are distinct.
The radius of gyration and the volume of correlation, calculated
from the SAXS profile, can be used to estimate the mass of
KpPqqD (38). The experimentally estimated KpPqqD molecu-
lar mass was determined to be 10.8 kDa, in agreement with the
predicted 10.4 kDa for the monomer of KpPqqD.
To visualize the discrepancies between the experimental and
the calculated values for Rg, Dmax, and Mr we fitted the experi-
mental SAXS data to generate a solution structure for KpPqqD.
The envelope for KpPqqD was generated by DAMMIF using
the experimental parameters defined by GNOM and P1 sym-
metry as constraints (24 –26). DAMMIF uses an initial beaded
model that is subjected to simulated annealing and compacting
until the shape of the model has a scattering pattern that fits the
experimental data with the imposed constraints (25). The
DAMMIF derived and experimentally fit model for KpPqqD
was shown to be globular in shape (Fig. 4A). The overlay of the
XcPqqD monomeric crystal structure in the solution structure
(Fig. 4A) further depicts the dissimilarity between the XcPqqD
crystal structure and the KpPqqD solution structure.
Although the oligomerization state is different, the XcPqqD
domain-swapped structure may still be informative about the
KpPqqD monomer. As suggested by a referee, we generated a
model of a compact monomer using the 1 and 2 strands from
one polypeptide chain and the 3, 1, 2, and 3 motifs from
the second polypeptide chain (highlighted in Fig. 2). The theo-
retical SAXS profile from the modeled XcPqqD fits the exper-
imental SAXS profile (Fig. 3E, red) reasonably well. Moreover,
the theoretical Rg for the model is 14.9 Å, similar to the exper-
imentally derived Rg  15.4 Å. We conclude that the compact
XcPqqD model is able to fit into the SAXS envelope (Fig. 4B).
Examination of the PqqE and PqqD Complex—A previous
study (21) from our lab has shown through EPR and hydrogen-
deuterium exchange that KpPqqD interacts with KpPqqE;
however, the binding affinity and stoichiometry were never
determined. To shed light on the binding ratio for the PqqD-
PqqE interaction we re-examined the formation of the complex
using native nanoflow Q-TOF-ESI-MS. Both KpPqqD (mono-
mer, 10,435 Da) and His6-KpPqqE (monomer, apoprotein,
45,077 Da) were exchanged into ammonium bicarbonate buffer
and analyzed individually. Only the 5	 and 6	 10.4 kDa mono-
mer ions of KpPqqD were detected, confirming that KpPqqD
PqqD Is a Peptide Chaperone
12912 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290 • NUMBER 20 • MAY 15, 2015
was a monomer in solution (Fig. 5A). The 12–14	 charged
45.9-kDa monomer ions of His6-KpPqqE were also clearly
detected (Fig. 5B). Upon analyzing a sample containing 40 M
KpPqqD and 10 M His6-KpPqqE, new 13	 and 14	 56.6 kDa
ions appeared (Fig. 5C). The mass of the new species is consis-
tent with a KpPqqD-KpPqqE complex with a 1:1 stoichiometry.
To determine whether the PqqD-PqqE interaction tran-
scends a single species, native mass spectrometry was applied to
the M. extorquens AM1 PQQ biosynthetic pathway. MePqqD
(monomer, 10,409 Da) and MePqqE-His6 (monomer, apopro-
tein, 42,612 Da) were buffer exchanged into ammonium bicar-
bonate and subjected to the same analysis as KpPqqD and
KpPqqE. The 5–7	 10.4 kDa ions of MePqqD were evident
from the mass spectra (Fig. 5D). The presence of only the mono-
meric form of MePqqD supports the notion that PqqD, in gen-
eral, is a monomer in solution. The 11–13	 43.6 kDa ions of the
MePqqE-His6 monomer and, to a lesser extent, the 18 –20	
86.9 kDa ions of the MePqqE-His6 dimer were clearly detected
in the mass spectra (Fig. 5E). Analysis of the 80 M MePqqD and
20 M MePqqE mixture led to the identification of new 13	
and 14	 charged 54.0 kDa ions (Fig. 5F) indicating that
MePqqD and MePqqE form a 1:1 complex and that the
interaction between PqqD and PqqE is not isolated to
K. pneumoniae.
SPR experiments were used to determine the dissociation
constant (KD) between MePqqD and MePqqE. Due to the non-
specific adsorbing of native MePqqD onto the SPR chip, we
used the His6-MePqqD as the ligand and native MePqqE as the
analyte. At 25 °C, the KD, determined from steady-state analy-
sis, was found to be 12.5  1.5 M (Table 1). The KD of 12 M
is supported, in part, by un-optimized isothermal calorimetry
(ITC) experiments that estimated a KD of 10 M (data not
FIGURE 3. SEC and SAXS analysis of KpPqqD. A, the analytical size exclusion chromatogram of purified KpPqqD monitoring tryptophan absorbance at 280 nm
shows a single peak with an elution volume that corresponds to a 14.9-kDa protein, calculated from the standard curve in B. B, the standard curve of the
molecular weight standards shows a linear relationship with elution volume (black points and line). The calculated molecular weight for KpPqqD is shown by
the red triangle. C, the similarity of the SAXS profiles for KpPqqD at all concentrations studied (1, 2, 3, 4, and 5 mg/ml: black, violet, dark blue, blue, and cyan,
respectively) is independent of protein concentration. D, the plot of the radius of gyration as a function of KpPqqD shows its independence of protein
concentration. E, experimental SAXS profile of KpPqqD (E) does not agree with the XcPqqD SAXS profiles calculated from the dimer (cyan line) or monomer
(blue line) crystal structures. However, the SAXS profile for KpPqqD does agree with the compact model of XcPqqD (red line), constructed as described in the text
and illustrated in Fig. 4B. F, the Guinier plot shows the linearity of the low q region of the experimental KpPqqD SAXS data extrapolated to zero scattering angle
(red line), indicating that the protein has not aggregated.
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shown). The relatively high KD prevented optimization of ITC
experiments due to the necessity of unreasonably high protein
concentrations.
PqqD Binds the Peptide PqqA—To determine the function of
MePqqD, we used SPR to screen for binding with the peptide
MePqqA. Maximum steady state SPR responses were plotted
versus peptide concentration and fitted to derive KD values (Fig.
6, A and B, represent typical datasets). MePqqD was found to
bind MePqqA with a KD of 390  80 nM (Table 1). We probed
the effects of PqqC being fused to PqqD and found that the
MePqqCD fusion bound MePqqA with a KD of 180  20 nM
(Table 1). Evidence for a PqqDE fusion protein can be found in
Methylocystis sp. SC2, which warranted the engineering of a
MePqqDE fusion protein with a flexible (GGGGS)4 linker to
determine whether PqqE interferes with PqqA binding. Sim-
ilar to MePqqCD and MePqqD, the KD for MePqqDE and
MePqqA interaction was found to be 200  30 nM. The sim-
ilar KD values for all constructs suggest that the presence of
either PqqC or PqqE does not impact the overall ability of
MePqqD to bind the peptide. In their as-isolated forms, nei-
ther MePqqB nor MePqqE was found to bind MePqqA. ITC
was used to independently verify the KD values for the bind-
ing of MePqqA to MePqqD, MePqqCD, and MePqqDE; the
values were found to be 130  30, 190  40, and 160  40 nM,
respectively (Table 1). Moreover, the ITC experiments esti-
mated the molar ratio between MePqqD constructs and
MePqqA to be 1:1 (Fig. 6C), consistent with native mass
spectrometry experiments (data not shown).
A dual injection SPR technique was used to determine the KD
of the MePqqAD complex to MePqqE. The first injection con-
sisted of 10 M MePqqA over the SPR chip with bound His6-
MePqqD. The second injection consisted of 10 M MePqqA
and various concentrations of native MePqqE. The KD of the
MePqqADE complex was determined to be 4.5  1.5 M (Table
1). To verify that a ternary MePqqADE complex was formed,
native mass spectra were obtained. Analysis of a sample con-
taining 50 M MePqqD, 50 M MePqqA, and 10 M MePqqE-
His6 led to the formation of new 13–15	 57.0 kDa ions (Fig. 7)
consistent with a 1:1:1 ternary MePqqA, MePqqD, and
MePqqE complex.
PqqD Can Be Found with Peptide Modifying RS-SPASM
Proteins—A bioinformatic approach was used to examine the
biological range of PqqD in relationship to RS-SPASM proteins.
From the 21,353 sequences listed under the SPASM domain
Interpro identifier (IPR023885), the generation of the sequence
similarity network yielded 1,882 nodes (Fig. 8). Each node rep-
resents a set of related protein sequences and contains a unique
representative sequence encoding for a SPASM domain pro-
tein. The representative sequence, in essence, is most similar to
all other proteins within the node. In principle, the representa-
tive sequence can be used to generalize for all sequences con-
tained within the node. Therefore, the gene context of repre-
sentative sequences for nodes that were found in a three-node
cluster or more (1,476 nodes) was manually inspected for the
presence of the PqqD homologue and a peptide. We found that
a PqqD homologue was fused to an RS-SPASM protein in 582
representative sequences. Moreover, a PqqD homologue was
found nearby an RS-SPASM protein in 179 representative
sequences (761 total representative sequences). Of the remain-
ing 715 representative sequences, 547 did not have a PqqD ho-
mologue annotated and 168 did not have gene information
available. The presence of a peptide was found in the gene con-
text of 292 of 761 (38%) representative sequences with a PqqD
homologue, whereas a peptide could only be found in the gene
context of 45 of 547 (8%) representative sequences without a
PqqD homologue.
DISCUSSION
PqqD has been shown, through gene knock-out and bioin-
formatic studies, to be an essential component for PQQ biosyn-
thesis (8, 14, 15). The crystal structure for XcPqqD indicates
that PqqD is a dimer and may form a scaffold for a larger mac-
romolecular complex (15). When we purified KpPqqD, how-
ever, we found that the protein eluted from the SEC column
later than was expected for the size of the dimer. Upon further
analytical SEC analysis we found a molecular weight for
KpPqqD that was closer to that of monomer than a dimer. We
therefore used SAXS as a means to determine the solution
molecular weight and, thereby, the oligomerization state of
KpPqqD. SAXS has been used to determine the molecular
FIGURE 4. Solution structure of KpPqqD. Ab initio SAXS reconstruction of
KpPqqD (mesh) shown as side-on views. A, the ribbon structure of the elon-
gated XcPqqD monomer (PDB code 3G2B) was docked into the SAXS enve-
lope demonstrating that the SAXS-reconstructed envelope and the crystal
structure are not in agreement. B, the ribbon structure of the compact
XcPqqD model, taken from the 1 and 2 strands from one polypeptide chain
and the 3, 1, 2, and 3 motifs from the second polypeptide chain, could
be docked into the reconstructed envelope.
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weight of proteins with an average error of 5% (29). This tech-
nique provides strong support for the existence of KpPqqD as a
monomer.
The difference in oligomerization states for crystallized
XcPqqD and solution KpPqqD warranted a further analysis. In
the crystal, XcPqqD adopts a saddle-like dimeric conformation
with each monomer, containing an -helix bundle and an
extended 1-2 hairpin feature, interlocked with the another
monomer by H-bonds and hydrophobic interactions in an
elongated 3 strand region (20). By contrast, in solution
KpPqqD adopts a monomeric globular structure that is quite
different from the crystallized dimer or the monomer of
XcPqqD. When the XcPqqD monomer is fit into the volume of
the KpPqqD solution structure it becomes evident that the
1-2 hairpin adopts an extended conformation. We postu-
lated that the positions of the 1 and 2 strands are compacted
in relationship to the -helix bundle of KpPqqD and that the
dimerization state, or domain swapped state, may either be an
innate property to XcPqqD or the result of the crystallographic
conditions. We proceeded to generate a model of a compact
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FIGURE 5. Nano-Q-TOF-ESI-MS characterization shows PqqD and PqqE form a 1:1 complex. Native mass spectra of K. pneumoniae (left panels) or M. extorquens
AM1 (right panels) PqqE with and without PqqD. A, the spectrum of KpPqqD shows a single population with a molecular mass of 10.4 kDa calculated from the charge
state distribution. B, likewise, the spectrum of KpPqqE shows a monomer population with a molecular mass of 45.9 kDa calculated from the charge state distribution.
C, in the presence of KpPqqD, a new charge state distribution, corresponding to a mass of 56.6 kDa, is formed consistent with a 1:1 KpPqqD-KpPqqE complex. D, the
MePqqD native mass spectrum shows a monomer population with a molecular mass of 10.4 kDa calculated from the charge state distribution. E, the native mass
spectrum of MePqqE shows two sets of charge state distributions with masses of 43.6 and 86.9 kDa, indicating that both the monomeric and dimeric species are
present. F, in the presence of MePqqD, a 54.0-kDa charge state distribution is formed corresponding to a 1:1 MePqqE-MePqqD complex.
TABLE 1
Dissociation constants for various protein-ligand or protein-protein
complexes determined by SPR or ITC
Complexes examined
KD
SPR ITC
M
His6-MePqqD 	 MePqqE 12.5  1.5 10a
His6-MePqqD 	 MePqqA 0.39  0.08 0.13  0.03
His6-MePqqCD 	 MePqqA 0.18  0.02 0.19  0.04
His6-MePqqDEfus 	 MePqqA 0.20  0.04 0.16  0.04
MePqqB-His6 	 MePqqA NDb –c
His6-MePqqE 	 MePqqA ND –c
MePqqA/His6-MePqqD 	 MePqqEd 4.5  1.5 –c
a The estimated value was obtained through unoptimized ITC experiments.
b ND, not detectable.
c Dash, not determined.
d MePqqA and His6-MePqqD were preformed prior to the addition of MePqqE.
Errors are standard deviations of three independent KD determinations.
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XcPqqD monomer consisting of the 1 and 2 strands from
one polypeptide chain and the 3, 1, 2, and 3 motifs from
the second polypeptide chain. The theoretical SAXS profile
matches the experimental SAXS profile for KpPqqD quite well.
Follow up experiments will be necessary to interrogate whether
the crystal structure of XcPqqD has implications for a relevant
conformational alteration that could facilitate the formation of
a tight complex with PqqA.
As mentioned before, the KpPqqD-KpPqqE interaction had
previously been discovered, although the KD, stoichiometry,
and how it relates to PQQ biosynthesis were not determined.
We re-examined the interaction by using native mass spec-
trometry to derive the stoichiometric ratios for the KpPqqD-
KpPqqE complex and found the molar ratio to be 1:1. We could
not probe for other protein-protein interactions within the
K. pneumonae PQQ pathway due to solubility issues with
FIGURE 6. Binding of PqqCD and PqqA observed by SPR and ITC. A representative dataset (His6-MePqqCD as ligand and MePqqA as analyte) showing that:
A, the SPR response increases as MePqqA concentration increases (blue to violet) and B, the steady state fits were used to calculate the dissociation constant
(error bars represent standard deviation of three independent experiments. C, ITC was used to independently verify the dissociation constants and determine
the molar ratio. The representative raw isotherm traces (top panel) and the integral data points (bottom panel) are shown for an experiment with MePqqA and
His6-MePqqCD (black) and a control experiment lacking His6-MePqqCD (blue). As discussed under “Experimental Procedures,” the first injection for each
experiment was omitted in data analysis. The single-site model fit curve generated for the experimental data is shown in red.
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FIGURE 7. Nano-Q-TOF-ESI-MS characterization of the MePqqA-MePqqD-
MePqqE complex. The native mass spectrum of a solution containing 50 M
MePqqA, 50 M MePqqD, and 10 M MePqqE shows two sets of charge state
distributions. The 12–13	 charged 43.6 kDa ions correspond to the MePqqE
monomer and the new 13–15	 charged 57.0 kDa ions correspond to a ter-
nary 1:1:1 MePqqA-MePqqD-MePqqE complex.
FIGURE 8. Representative sequence similarity network for the SPASM
domain family. Each node (oval) represents a group of sequences where
each sequence in the node is at least 60% identical to the representative
sequence that defines the node (computed by the CD-HIT program (33)). The
1,882 nodes shown in this network represent over 20,000 sequences. Each
edge (lines) that connects two nodes represents a BLAST similarity score of an
-log(E-value) of 45 or greater, alignments of lengths between 340 and 450
amino acids (typical length of RS-SPASM proteins) and an average sequence
identity of 35%. Cytoscape was used to visualize the network yFiles in an
organic layout. The gene contexts of representative sequences were exam-
ined for the presence of a PqqD homologue and a peptide within a 5-gene
region on the same DNA strand. A node is colored blue if the representative
sequence was fused to or found nearby a PqqD orthologue and a peptide was
present in the gene context. A node is colored red if the representative
sequence was fused to or found nearby a PqqD orthologue but a peptide was
not found in the gene context. A node is colored yellow if the representative
sequence was not fused to or found nearby a PqqD orthologue and a peptide
was found in the gene context. A node is colored in gray if the representative
sequence is not fused to or found nearby a PqqD orthologue and a peptide
was not found in the gene context or the gene information was unavailable.
Nodes colored in black were not analyzed.
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KpPqqB and the peptide substrate KpPqqA, prompting the
move to the M. extorquens AM1 PQQ pathway. In M. exo-
torquens AM1, the PQQ biosynthetic pathway consists of the
operon pqqAB(CD)E where pqqC and pqqD are a gene fusion.
All M. extorquens AM1 pqq genes were cloned into E. coli
expression vectors and were found to be soluble.
Native mass spectrometry experiments were used to verify a
MePqqD-MePqqE complex and clearly demonstrated that the
interaction transcends species. Moreover, the mass spectra
confirmed the 1:1 molar ratio of the MePqqD-MePqqE com-
plex. The KD for the MePqqD-MePqqE interaction, determined
by SPR, is found to be 12 M. The relatively weak KD may
suggest that the MePqqD-MePqqE interaction is transient (39).
We attempted to determine the stoichiometry of the complex
by analytical SEC but found that the complex did not remain
intact under these conditions. Using the as isolated form of
MePqqB, no interactions have been detected between MePqqD
or MePqqE through native mass spectrometry. We did not
probe for any protein interactions with PqqC because gene
knock-out studies have shown that in the absence of PqqC, the
intermediate AHQQ is still formed (8). The fact that AHQQ
can be formed decreases the likelihood that a functionally rele-
vant protein complex with PqqC is necessary. The native mass
spectral data suggest that the major protein-protein interaction
in the PQQ pathway is between MePqqD and MePqqE.
In a brute force effort to discover the binding partner for the
peptide PqqA, we utilized SPR and ITC to screen for binding
events between MePqqA and MePqqB, MePqqE, and MePqqD.
Surprisingly, we find that MePqqD binds MePqqA tightly (KD
 200 –300 nM depending on the construct). In contrast, evi-
dence for peptide binding by MePqqE or MePqqB was not
found. Significantly, these experiments provide the first evi-
dence that PqqD is the PqqA binding partner. Moreover, to the
best of our knowledge, this is the first instance that a PqqD
homologue has been shown to bind a peptide.
Taking into account the interaction between MePqqD and
MePqqE, we also probed for a MePqqA-D-E complex. Native
mass spectrometry experiments provided evidence for a ter-
nary complex and the molar ratio was determined to be 1:1:1.
The KD between the MePqqAD complex and MePqqE is 4.5
M, by a dual injection SPR technique, about the same as the KD
determined for MePqqD and MePqqE. The similar KD values
between MePqqE and MePqqD or MePqqAD suggest that the
presence of the peptide does not assist in PqqD-PqqE complex
formation. The binding data determined here provides a new
picture of the first steps in PQQ biosynthesis. Our new hypoth-
esis is that PqqD first binds PqqA to protect the peptide from
premature proteolytic cleavage and/or to present the glutamate
and tyrosine to PqqE. PqqE then binds the PqqAD complex and
catalyzes the formation of the carbon-carbon bond between the
glutamate and tyrosine.
The idea that the RS-SPASM protein directly acts on the
peptide is consistent with other post-translational pathways
such as in subtilosin biosynthesis. In subtilosin biosynthesis, the
peptide is directly modified by AlbA (40). Moreover, our bioin-
formatic analysis supports, in part, the notion that a function-
ally relevant interaction between a PqqD homologue and an
RS-SPASM protein exists in peptide modification pathways.
Not only does AlbA contain a N-terminal PqqD orthologue,
other RS-SPASM proteins can be found with a PqqD ortho-
logue fused to or near the RS-SPASM gene (e.g. the putative
mycofactocin pathway, the Pep1357C pathway, and in the puta-
tive 6 cysteines in 45 modification pathway). The exact role of
the PqqD homologues in other peptide modification pathways
will need to be addressed; however, from the work presented
here, we propose that PqqD is a peptide chaperone that forms a
stable complex with PqqA.
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